Drugs / DermACELL
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2/3 | NCT03476876 | Apr 2018 → Oct 2020 | ulcer of lower limbs | Baylor College of Medicine | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | DermACELL | “DermACELL (LifeNet Health,Virginia Beach, VA) is acellular dermal matrices (ADM), which has been shown to be effective in treating chronic DFUs in a clinical trial.” NCT03476876 ↗ |
| Modality | Other / unclassified | “DermACELL (LifeNet Health,Virginia Beach, VA) is acellular dermal matrices (ADM)” NCT03476876 ↗ |